Commercialization of Personalized Medicines

QuickSTAT Pharma Industry
Over the course of the last decade, there has been an increased emphasis on research and development into personalized medicines including cell, gene and immunotherapy treatments. With a forecasted compounded annual growth rate of 8.74%, the market is expected to reach $149 billion by 2020. This pos...

You need to to read full article


Not yet a member?

Joing GCSG to have full access of our educational resources and gain access to our member directory, filled with more than 450 collegues.

register now see membership features